CA0636711016 - Common Stock

**BMO** gets a fundamental rating of **3** out of 10. The analysis compared the fundamentals against 416 industry peers in the **Banks** industry. **BMO** has a bad profitability rating. Also its financial health evaluation is rather negative. **BMO** has a decent growth rate and is not valued too expensively. **BMO** also has an excellent dividend rating.

In the past year **BMO** was profitable.

In the past 5 years **BMO** has always been profitable.

With a **Return On Equity** value of **9.38%**, **BMO** is not doing good in the industry: **63.37%** of the companies in the same industry are doing better.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.56% | ||

ROE | 9.38% | ||

ROIC | N/A |

ROA(3y)0.81%

ROA(5y)0.75%

ROE(3y)13.45%

ROE(5y)12.55%

ROIC(3y)N/A

ROIC(5y)N/A

In the last couple of years the **Profit Margin** of **BMO** has grown nicely.

The **Operating Margin** and **Gross Margin** are not available for **BMO** so they could not be analyzed.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | N/A | ||

PM (TTM) | 20.82% | ||

GM | N/A |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y20.95%

PM growth 5Y10.56%

GM growth 3YN/A

GM growth 5YN/A

Compared to 1 year ago, **BMO** has more shares outstanding

With a **Debt to FCF ratio** value of **7.96**, **BMO** is not doing good in the industry: **76.14%** of the companies in the same industry are doing better.

Looking at the **Debt to Equity ratio**, with a value of **2.31**, **BMO** is doing worse than **93.73%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 2.31 | ||

Debt/FCF | 7.96 | ||

Altman-Z | N/A |

ROIC/WACCN/A

WACC7.31%

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | N/A | ||

Quick Ratio | N/A |

The earnings per share for **BMO** have decreased strongly by **-11.60%** in the last year.

Looking at the last year, **BMO** shows a quite strong growth in **Revenue**. The Revenue has grown by **12.44%** in the last year.

The **Revenue** has been growing by **9.34%** on average over the past years. This is quite good.

EPS 1Y (TTM)-11.6%

EPS 3Y12%

EPS 5Y10.23%

EPS growth Q2Q-10.03%

Revenue 1Y (TTM)12.44%

Revenue growth 3Y10.68%

Revenue growth 5Y9.34%

Revenue growth Q2Q30%

Based on estimates for the next years, **BMO** will show a decrease in **Earnings Per Share**. The EPS will decrease by **-0.76%** on average per year.

Based on estimates for the next years, **BMO** will show a small growth in **Revenue**. The Revenue will grow by **6.02%** on average per year.

EPS Next Y-9.21%

EPS Next 2Y-1.78%

EPS Next 3Y-0.76%

EPS Next 5YN/A

Revenue Next Year15.18%

Revenue Next 2Y11.03%

Revenue Next 3Y8.7%

Revenue Next 5Y6.02%

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

Based on the **Price/Earnings** ratio of **9.08**, the valuation of **BMO** can be described as reasonable.

Compared to the rest of the industry, the **Price/Earnings** ratio of **BMO** is on the same level as its industry peers.

Based on the **Price/Forward Earnings** ratio, **BMO** is valued a bit cheaper than 67.23% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 9.08 | ||

Fwd PE | 8.5 |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 3.48 | ||

EV/EBITDA | N/A |

PEG (NY)N/A

PEG (5Y)0.89

EPS Next 2Y-1.78%

EPS Next 3Y-0.76%

With a **Yearly Dividend Yield** of **5.34%**, **BMO** is a good candidate for dividend investing.

Compared to an average industry **Dividend Yield** of **3.96**, **BMO** pays a better dividend. On top of this **BMO** pays more dividend than 80.72% of the companies listed in the same industry.

Compared to an average S&P500 **Dividend Yield** of **2.63**, **BMO** pays a better dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 5.34% |

The dividend of **BMO** has a limited annual growth rate of **4.75%**.

The dividend of **BMO** decreased recently.

Dividend Growth(5Y)4.75%

Div Incr Years1

Div Non Decr Years1

DP38.53%

EPS Next 2Y-1.78%

EPS Next 3Y-0.76%

**BANK OF MONTREAL**

NYSE:BMO (11/28/2023, 7:04:00 PM)

After market: 79.93 0 (0%)**79.93**

**-0.68 (-0.84%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupBanks

GICS IndustryBanks

Earnings (Last)08-29 2023-08-29/bmo

Earnings (Next)12-01 2023-12-01/bmo

Inst Owners46.59%

Inst Owner Change1.9%

Ins Owners0%

Ins Owner Change0%

Market Cap57.00B

Analysts72

Price Target95.05 (18.92%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 5.34% |

Dividend Growth(5Y)4.75%

DP38.53%

Div Incr Years1

Div Non Decr Years1

Ex-Date10-27 2023-10-27 (1.47)

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-10.69%

Min EPS beat(2)-12.19%

Max EPS beat(2)-9.19%

EPS beat(4)1

Avg EPS beat(4)-5.64%

Min EPS beat(4)-12.19%

Max EPS beat(4)0.77%

Revenue beat(2)1

Avg Revenue beat(2)0.46%

Min Revenue beat(2)-2.52%

Max Revenue beat(2)3.44%

Revenue beat(4)2

Avg Revenue beat(4)9.27%

Min Revenue beat(4)-13.62%

Max Revenue beat(4)49.76%

PT rev (1m)-0.85%

PT rev (3m)-6.94%

EPS NQ rev (1m)-0.54%

EPS NQ rev (3m)-7.22%

EPS NY rev (1m)0%

EPS NY rev (3m)-5.46%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-1.92%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-2.04%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 9.08 | ||

Fwd PE | 8.5 | ||

P/S | 2.32 | ||

P/FCF | 3.48 | ||

P/OCF | 3.24 | ||

P/B | 1.04 | ||

P/tB | 1.46 | ||

EV/EBITDA | N/A |

EPS(TTM)8.8

EY11.01%

EPS(NY)9.4

Fwd EY11.76%

FCF(TTM)22.96

FCFY28.73%

OCF(TTM)24.64

OCFY30.82%

SpS34.45

BVpS76.49

TBVpS54.8

PEG (NY)N/A

PEG (5Y)0.89

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.56% | ||

ROE | 9.38% | ||

ROCE | N/A | ||

ROIC | N/A | ||

ROICexc | N/A | ||

ROICexgc | N/A | ||

OM | N/A | ||

PM (TTM) | 20.82% | ||

GM | N/A | ||

FCFM | 66.64% |

ROA(3y)0.81%

ROA(5y)0.75%

ROE(3y)13.45%

ROE(5y)12.55%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y20.95%

PM growth 5Y10.56%

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.03

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 2.31 | ||

Debt/FCF | 7.96 | ||

Debt/EBITDA | N/A | ||

Cap/Depr | 86.4% | ||

Cap/Sales | 4.87% | ||

Interest Coverage | N/A | ||

Cash Conversion | N/A | ||

Profit Quality | 320.12% | ||

Current Ratio | N/A | ||

Quick Ratio | N/A | ||

Altman-Z | N/A |

F-Score4

WACC7.31%

ROIC/WACCN/A

Cap/Depr(3y)79.82%

Cap/Depr(5y)90.32%

Cap/Sales(3y)3.97%

Cap/Sales(5y)4.04%

Profit Quality(3y)542.24%

Profit Quality(5y)491.56%

Growth

EPS 1Y (TTM)-11.6%

EPS 3Y12%

EPS 5Y10.23%

EPS growth Q2Q-10.03%

EPS Next Y-9.21%

EPS Next 2Y-1.78%

EPS Next 3Y-0.76%

EPS Next 5YN/A

Revenue 1Y (TTM)12.44%

Revenue growth 3Y10.68%

Revenue growth 5Y9.34%

Revenue growth Q2Q30%

Revenue Next Year15.18%

Revenue Next 2Y11.03%

Revenue Next 3Y8.7%

Revenue Next 5Y6.02%

EBIT growth 1YN/A

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y78.35%

FCF growth 3Y-50.06%

FCF growth 5Y10.64%

OCF growth 1Y77.79%

OCF growth 3Y-44.69%

OCF growth 5Y11.26%